SECAUCUS, N.J., March 1, 2017 /PRNewswire/ -- Vitamin Shoppe, Inc. (NYSE: VSI), a multi-channel, specialty retailer and manufacturer of nutritional products, today announced preliminary results for the three months ended December 31, 2016. Total net sales in the fourth quarter were $304.9 million, up 3.9% with the same period of the prior year. Reported fully diluted loss per share in fourth quarter 2016 was $0.49, compared to fully diluted earnings per share of $0.22 in fourth quarter 2015. Results in fourth quarter 2016 include a $39.2 million, or $0.98 per share, impairment charge associated with Nutri-Force goodwill and other intangible assets and a $3 million tax benefit from the closure of the Canadian stores earlier in the year, while fourth quarter 2015 results include approximately $7.4 million, or $0.17 per diluted share, of certain costs primarily related to strategic initiatives. Excluding these items in both periods, adjusted EPS was $0.36 and $0.39, in fourth quarter 2016 and 2015, respectively. (Refer to Table 4 at the end of this press release.) Additionally, 2016 was a 53-week year and the extra week added approximately $0.08 to EPS.

Commenting on the quarter's results, Colin Watts, Chief Executive Officer of the Vitamin Shoppe stated, "Our top line growth is not yet where we want it to be as fourth quarter comparable sales were disappointing, but generally in line with our expectations. Although the external environment was more difficult than we planned coming into 2016, we made significant progress in rolling out initiatives tied to our reinvention strategy. While we are encouraged by the early results of these programs in 2016, we acknowledge that they will still take time to reach full scale. In addition to good progress on growth initiatives during the quarter, we were particularly pleased with accelerated progress in our cost reduction and margin enhancement initiatives, which are vital to building a stronger Return on Capital profile for our Company in 2017. We still have a ways to go to realize our full Reinvention vision, but we remain bullish about our long-term prospects for sustainable, profitable growth."

Fourth Quarter 2016 Results

Total sales of $304.9 million in the quarter increased 3.9% over the same period of the prior year. Total comparable sales were down 2.2% in the quarter driven by a 1.8% decline in retail store comparable sales and a 5.0% decrease in total e-commerce comparable sales. Included in e-commerce comp sales, vitaminshoppe.com comparable sales increased 7%. Manufacturing third party sales decreased 28.9% from the same period of the prior year. The Company opened three stores in the quarter and closed two.

Cost of goods sold, which includes product, distribution, manufacturing and store occupancy costs, increased $2.5 million, or 1.2%, to $204.7 million for the three months ended December 31, 2016, compared with $202.2 million for the three months ended December 26, 2015.

Gross profit of $100.2 million was up 9.7% from $91.3 million in fourth quarter 2015. Gross profit as a percentage of net sales was 32.9% in fourth quarter 2016, compared to 31.1% in the same period of 2015. Gross margin in fourth quarter 2015 includes approximately $2.6 million in inventory related charges for Super Supplements conversion, inventory write-off for customer which went out of business and Canada store closings. Excluding the impact of these charges as detailed in Table 4, gross margin in fourth quarter 2015 was 32.0%. The fourth quarter 2016 year over year increase was primarily due to product margin improvement and leverage in occupancy and supply chain costs due to the 53(rd) week.

Selling, general and administrative expenses (SG&A), including operating payroll and related benefits, advertising expense and depreciation and amortization, increased $42.7 million to $122.8 million for the quarter ended December 31, 2016, compared with $80.2 million for the quarter ended December 26, 2015. SG&A in fourth quarter 2016 includes $39.2 million of impairment charges for Nutri-Force. SG&A for fourth quarter 2015 included total costs of $4.9 million primarily related to reinvention and management realignment costs and Super Supplements conversion expenses. Excluding certain items for both periods, SG&A as a percent of revenue was 27.4% in fourth quarter 2016 and 25.7% in fourth quarter 2015. (For further information on adjustments see Table 4 at the end of this release.) The increase in the SG&A rate was primarily driven by deleverage from lower sales.

Loss from operations in fourth quarter 2016 of $22.7 million compared to operating income of $11.1 million in the same period of the prior year. Adjusted for the items noted in the preceding paragraph, income from operations as a percentage of sales was 5.4% in fourth quarter 2016 and 6.3% in fourth quarter 2015. (See Table 4.)

Net loss was $11.6 million for fourth quarter 2016 compared to net income of $6.1 million in the same period of the prior year. Reported fully diluted loss per share was $0.49 in fourth quarter 2016, compared to fully diluted earnings per share of $0.22 in fourth quarter 2015. EPS, on an adjusted basis (for the items described in Table 4), was $0.36 and $0.39 for the fourth quarters of 2016 and 2015, respectively.

Balance Sheet and Cash Flow

Cash and equivalents at December 31, 2016 were $2.8 million. At quarter end, the Company had $11 million drawn on the revolving line of credit and a convertible notes liability of $121 million.

Capital expenditures were $8.8 million in the quarter. Funds were primarily expended on new and remodel stores, supply chain, digital and other IT investments.

During the quarter, the Company repurchased 0.4 million shares of its common stock, or approximately 2.0% of the shares outstanding, for a total purchase price of $10.0 million.

Full Year 2016 Financial and Operating Highlights


    --  Opened 26 stores
    --  Transformed 4 stores into new reinvented stores
    --  Launched new responsive website
    --  Total revenue increased 1.8%
    --  Total comparable sales were down 0.9%
    --  GAAP fully diluted earnings per share of $1.04, or $2.09 per fully
        diluted share excluding certain costs.  This compares with fully diluted
        earnings per share of $1.82 or an adjusted $2.11 per share, in 2015. 
        See Table 4.
    --  Repurchased 2.6 million common shares for a total of $66.0 million.

2017 Outlook

Management is providing the following outlook for 2017:


    --  Total comparable sales growth flat to low single digit negative
    --  The opening of 15 new stores
    --  Remodel 10 to 15 stores into new format
    --  Fully diluted earnings per share in the range of $1.95 - $2.20.  This
        excludes any potential charges associated with the implementation of
        strategic initiatives to improve performance at Nutri-Force.
    --  Capital expenditures of approximately $45 million

Non-GAAP Financial Measures

Adjusted information is non-GAAP financial information. These supplemental non-GAAP measures should not be considered superior to, or a substitute for, and should be considered in conjunction with the GAAP financial measures presented. The Company believes such non-GAAP financial information facilitates analysis and comparisons of our ongoing business operations because it excludes items that may not be indicative of, or are unrelated to the Company's and our business segments' core operating performance, and may assist investors with comparisons to prior periods and assessing trends in our underlying businesses. These adjustments are consistent with how management views our businesses. Management uses such non-GAAP financial information in making financial, operating and planning decisions and evaluating the Company's and each business segment's ongoing performance. A reconciliation of adjusted financial information to the most directly comparable financial measures calculated and presented in accordance with GAAP is shown in Table 4.

Webcast
Management will host a conference call to discuss the fourth quarter 2016 results at 8:30a.m. Eastern Time (ET) today. Interested investors and other parties may listen to the simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company's website at www.vitaminshoppe.com. A powerpoint presentation to accompany the call can be found on the website in the Investor Relations section. A telephonic replay will be available beginning at 11:30 a.m. ET on March 1, 2017 and can be accessed by dialing 1-844-512-2921 or 1-412-317-6671 for international callers. The passcode for the replay is 9786140. The telephonic replay will be available until 11:59 p.m. ET on March 8, 2017. The webcast will also be archived on the company's website at www.vitaminshoppe.com in the investor relations section.

About the Vitamin Shoppe, Inc. (NYSE:VSI)

Vitamin Shoppe is a multi-channel, specialty retailer and contract manufacturer of nutritional products based in Secaucus, New Jersey. In its stores and on its website, the Company carries a comprehensive retail assortment including: vitamins, minerals, specialty supplements, herbs, sports nutrition, homeopathic remedies, green living products, and beauty aids. In addition to offering products from approximately 900 national brands, the Vitamin Shoppe also carries products under The Vitamin Shoppe(®), BodyTech(®), True Athlete(®), MyTrition(®), plnt(®), ProBioCare(®), Next Step(® )and Betancourt Nutrition(® )brands. The Vitamin Shoppe conducts business through more than 775 company-operated retail stores under The Vitamin Shoppe and Super Supplements retail banners, and through its website, www.vitaminshoppe.com. Follow the Vitamin Shoppe on Facebook at http://www.facebook.com/THEVITAMINSHOPPE and on Twitter at http://twitter.com/VitaminShoppe.

Forward Looking Statements

This press release contains "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including without limitation, statements under the caption "2017 Outlook", statements regarding future financial results and performance, share repurchases, future business prospects, revenue, new stores, product offerings, store growth, working capital, liquidity, capital expenditures, capital needs and interest costs, industry based factors, including the level of competition in the vitamin, mineral and supplement industry, continued demand from the primary markets the Company serves, consumer perception of the Company's products, the availability of raw materials as well as economic conditions generally and factors more specific to the Company such as compliance with manufacturing regulations, certifications and practices and restrictions imposed by the Company's revolving credit facility, including financial covenants and limitations on the Company's ability to incur additional indebtedness and the Company's future capital requirements, and other risks, uncertainties and factors set forth under Item 1A., entitled "Risk Factors", in the Company's Annual Report on Form 10-K for the fiscal year ended December26, 2015 and in the Company's other reports and documents filed with the SEC. These forward-looking statements can be identified by the use of words such as "outlook", "believes", "expects", "potential", "continues", "may", "will", "should", "seeks", "predicts", "intends", "plans", "estimates", "anticipates", "target", "could" or the negative version of these words or other comparable words. These statements are subject to various risks and uncertainties, many of which are outside the Company's control, including, among others the strength of the economy, changes in the overall level of consumer spending, the performance of the Company's products within the prevailing retail environment, trade restrictions, availability of suitable store locations at appropriate terms, the availability of raw material and other specific factors discussed herein and in other Company SEC filings (including reports on Forms 10-K and 10-Q filed with the SEC). The Company believes that all forward-looking statements are based on reasonable assumptions when made; however, it is impossible to predict actual results or outcomes or the effects of risks, uncertainties or other factors on anticipated results or outcomes with certainty and that, accordingly, one should not place undue reliance on these statements. Forward-looking statements speak only as of the date when made and the Company undertakes no obligation to update these statements in light of subsequent events or developments. Actual results may differ materially from anticipated results or outcomes discussed in any forward-looking statement.


                                                                          TABLE 1

                                                            VITAMIN SHOPPE, INC. AND SUBSIDIARY

                                                             CONSOLIDATED STATEMENTS OF INCOME

                                                      (In thousands, except share and per share data)

                                                                        (Unaudited)


                                                    Three Months Ended                                Fiscal Year Ended
                                                    ------------------                                -----------------

                                                       December 31,                                      December 26,              December 31,            December 26,

                                                                           2016                                               2015                    2016                    2015
                                                                           ----                                               ----                    ----                    ----


    Net sales                                                          $304,865                                           $293,490              $1,289,243              $1,266,549

    Cost of goods sold                                                  204,705                                            202,193                 862,887                 847,634
                                                                        -------                                            -------                 -------                 -------

    Gross profit                                                        100,160                                             91,297                 426,356                 418,915

    Selling, general and administrative expenses                        122,842                                             80,180                 380,779                 329,922
                                                                        -------                                             ------                 -------                 -------

    Income (loss) from operations                                      (22,682)                                            11,117                  45,577                  88,993

    Interest expense, net                                                 2,546                                                590                   9,523                   1,105
                                                                          -----                                                ---                   -----                   -----

    Income (loss) before provision for income taxes                    (25,228)                                            10,527                  36,054                  87,888

    Provision for (benefit from) income taxes                          (13,614)                                             4,395                  11,090                  34,717
                                                                        -------                                              -----                  ------                  ------

    Net income (loss)                                                 $(11,614)                                            $6,132                 $24,964                 $53,171
                                                                       ========                                             ======                 =======                 =======


    Weighted average common shares outstanding

       Basic                                                         23,357,556                                         28,102,790              23,875,540              28,954,804

       Diluted                                                       23,552,982                                         28,300,462              24,067,686              29,203,429

    Net income (loss) per common share

       Basic                                                            $(0.50)                                             $0.22                   $1.05                   $1.84

       Diluted                                                          $(0.49)                                             $0.22                   $1.04                   $1.82


                                                                                        TABLE 2

                                                                          VITAMIN SHOPPE, INC. AND SUBSIDIARY

                                                                SEGMENT DATA, KEY PERFORMANCE INDICATORS AND STORE INFO

                                                                                   ($ in thousands)

                                                                                      (Unaudited)


                                                                 Three Months Ended                                     Fiscal Year Ended
                                                                 ------------------                                     -----------------

                                                                    December 31,                                           December 26,              December 31,              December 26,

                                                                                            2016                                              2015                      2016                      2015
                                                                                            ----                                              ----                      ----                      ----

    Net sales:

                       Retail                                                             $262,144                                          $244,727                $1,109,202                $1,081,123

                       Direct                                                               31,078                                            32,381                   130,024                   128,825

                       Manufacturing                                                        21,989                                            23,974                    87,684                    91,159
                                                                                          ------

                       Segment net sales                                                   315,211                                           301,082                 1,326,910                 1,301,107

                       Elimination of intersegment revenues                               (10,346)                                          (7,592)                 (37,667)                 (34,558)

    Net sales                                                                           $304,865                                          $293,490                $1,289,243                $1,266,549
                                                                                        ========                                          ========                ==========                ==========


    Income (loss) from operations:

                       Retail                                                              $44,921                                           $37,036                  $197,450                  $192,598

                       Direct                                                                4,553                                             4,928                    18,737                    20,904

                       Manufacturing                                                      (41,405)                                            (544)                 (44,223)                  (1,977)

                       Corporate costs                                                    (30,751)                                         (30,303)                (126,387)                (122,532)

    Income (loss) from operations                                                      $(22,682)                                          $11,117                   $45,577                   $88,993
                                                                                        ========                                           =======                   =======                   =======


    Increase (Decrease) in total comparable net sales                                     (2.2)%                                           (0.3)%                   (0.9)%                    0.0 %

    Increase (Decrease) in comparable store net sales                                     (1.8)%                                           (0.9)%                   (1.5)%                    0.1 %

    Increase (Decrease) in e-commerce comparable net sales                                (5.0)%                                            3.9 %                    3.8 %                   (0.6)%


    Gross profit as a percent of net sales                                                32.9 %                                           31.1 %                   33.1 %                   33.1 %

    Income (loss) from operations as a percent of net sales                               (7.4)%                                            3.8 %                    3.5 %                    7.0 %


    Capital Expenditures                                                                  $8,840                                            $9,231                   $40,068                   $39,403

    Depreciation and Amortization                                                         $9,968                                           $10,038                   $38,780                   $38,495


    Store Data:

                       Stores open at beginning of period                                      774                                               748                       758                       717

                           Stores opened                                                         3                                                11                        26                        50

                           Stores closed                                                       (2)                                              (1)                      (9)                      (9)

                       Stores open at end of period                                            775                                               758                       775                       758
                                                                                             ===


    Total retail square footage at end of period (in thousands)                            2,709                                             2,662                     2,709                     2,662




                                                                                                                                                        TABLE 3

                                                                                                                                          VITAMIN SHOPPE, INC. AND SUBSIDIARY

                                                                                                                                              CONSOLIDATED BALANCE SHEETS

                                                                                                                                    (In thousands, except share and per share data)

                                                                                                                                                      (Unaudited)


                                                                                                                                                                                    December 31,          December 26,

                                                                                                                                                                                                     2016                  2015
                                                                                                                                                                                                     ----                  ----

                                                                                                                          ASSETS

    Current assets:

      Cash and cash equivalents                                                                                                                                                                    $2,833               $15,104

      Accounts receivable, net of allowance of $1,061 and $897 in 2016 and 2015, respectively                                                                                                       7,367                 7,437

      Inventories                                                                                                                                                                                 241,736               226,830

      Prepaid expenses and other current assets                                                                                                                                                    33,717                25,194

         Total current assets                                                                                                                                                                     285,653               274,565

    Property and equipment, net                                                                                                                                                                   139,132               140,158

    Goodwill                                                                                                                                                                                      210,633               243,269

    Other intangibles, net                                                                                                                                                                         79,489                87,270

    Other long-term assets                                                                                                                                                                         19,277                 3,429

    Total assets                                                                                                                                                                                 $734,184              $748,691
                                                                                                                                                                                                 ========              ========


                                                                                                           LIABILITIES AND STOCKHOLDERS' EQUITY

    Current liabilities:

      Revolving credit facility                                                                                                                                                                   $11,000                $8,000

      Accounts payable                                                                                                                                                                             65,606                41,217

      Deferred sales                                                                                                                                                                                5,209                20,483

      Accrued expenses and other current liabilities                                                                                                                                               52,290                47,776

         Total current liabilities                                                                                                                                                                134,105               117,476

    Convertible notes, net                                                                                                                                                                        120,874               115,410

    Deferred rent                                                                                                                                                                                  37,489                39,889

    Other long-term liabilities                                                                                                                                                                     1,720                   615


    Commitments and contingencies


    Stockholders' equity:

      Preferred stock, $0.01 par value; 250,000,000 shares authorized and no shares issued

       and outstanding at December 31, 2016 and December 26, 2015                                                                                                                                       -                    -

      Common stock, $0.01 par value; 400,000,000 shares authorized, 23,585,240 shares issued and

         23,424,055 shares outstanding at December 31, 2016, and 25,993,715 shares issued and 25,873,581

         shares outstanding at December 26, 2015                                                                                                                                                      236                   260

      Additional paid-in capital                                                                                                                                                                   80,727               139,827

      Treasury stock, at cost; 161,185 shares at December 31, 2016 and 120,134 shares at December 26, 2015                                                                                        (6,430)              (5,225)

      Accumulated other comprehensive loss                                                                                                                                                              -                 (60)

      Retained earnings                                                                                                                                                                           365,463               340,499

               Total stockholders' equity                                                                                                                                                         439,996               475,301
                                                                                                                                                                                                  -------               -------

    Total liabilities and stockholders' equity                                                                                                                                                   $734,184              $748,691
                                                                                                                                                                                                 ========              ========


                                                                                                                                                                     TABLE 4

                                                                                                                                                       VITAMIN SHOPPE, INC. AND SUBSIDIARY

                                                                                                                                                           SUPPLEMENTAL OPERATING DATA

                                                                                                                                                                   (Unaudited)


    Amounts in millions except per share data

    Figures may not sum due to rounding

                                                                                                                                                                                                        Operating         Net

                                                                                                                                                  Gross                                                    Income         Income          Diluted

                                                                                                                                                 Profit                                    SG&A            (Loss)         (Loss)            EPS
                                                                                                                                                 ------                                    ----             -----          -----            ---


    Three months ended December 31, 2016:
    -------------------------------------

    As Reported                                                                                                                                               $100.2                             $122.8           $(22.7)        $(11.6)           $(0.49)


    Impairment charges on goodwill and intangible asset (1)                                                                                                        -                            (39.2)             39.2            23.2               0.98


    Canada stores closing costs (2)                                                                                                                                -                                 -                -          (3.0)            (0.13)


    As Adjusted                                                                                                                                               $100.2                              $83.6             $16.5            $8.6              $0.36
                                                                                                                                                              ======                              =====             =====            ====              =====


    Three months ended December 26, 2015:
    -------------------------------------

    As Reported                                                                                                                                                $91.3                              $80.2             $11.1            $6.1              $0.22


    Management realignment charges (3)                                                                                                                             -                             (1.2)              1.2             0.8               0.03


    Reinvention strategy costs (4)                                                                                                                                 -                             (1.7)              1.7             1.1               0.04


    Integration costs (5)                                                                                                                                          -                             (0.5)              0.5             0.3               0.01


    Super Supplements conversion costs (6)                                                                                                                       1.0                              (0.8)              1.8             1.1               0.04


    Product write-off (7)                                                                                                                                        1.3                                  -              1.3             0.8               0.03


    Canada stores closing costs (2)                                                                                                                              0.3                              (0.6)              0.9             0.9               0.03


    As Adjusted                                                                                                                                                $93.8                              $75.3             $18.5           $11.1              $0.39
                                                                                                                                                               =====                              =====             =====           =====              =====


    Fiscal year ended December 31, 2016:
    ------------------------------------

    As Reported                                                                                                                                               $426.4                             $380.8             $45.6           $25.0              $1.04


    Impairment charges on goodwill and intangible asset (1)                                                                                                        -                            (39.2)             39.2            23.2               0.96


    Cost reduction project (8)                                                                                                                                     -                             (3.8)              3.8             2.3               0.10


    Canada stores closing costs (2)                                                                                                                            (0.2)                             (2.1)              1.9           (1.1)            (0.05)


    Super Supplements conversion costs (6)                                                                                                                     (0.2)                             (1.3)              1.0             0.6               0.03


    Reinvention strategy costs (4)                                                                                                                                 -                             (0.5)              0.5             0.3               0.01


    As Adjusted                                                                                                                                               $426.0                             $333.9             $92.0           $50.3              $2.09
                                                                                                                                                              ======                             ======             =====           =====              =====


    Fiscal year ended December 26, 2015:
    ------------------------------------

    As Reported                                                                                                                                               $418.9                             $329.9             $89.0           $53.2              $1.82


    Management realignment charges (3)                                                                                                                             -                             (3.4)              3.4             2.1               0.07


    Reinvention strategy costs (4)                                                                                                                                 -                             (2.7)              2.7             1.7               0.06


    Integration costs (5)                                                                                                                                          -                             (1.9)              1.9             1.2               0.04


    Super Supplements conversion costs (6)                                                                                                                       1.0                              (0.8)              1.8             1.1               0.04


    Account receivable bad debt reserve charge (9)                                                                                                                 -                             (1.4)              1.4             0.8               0.03


    Product write-off (7)                                                                                                                                        1.3                                  -              1.3             0.8               0.03


    Canada stores closing costs (2)                                                                                                                              0.3                              (0.6)              0.9             0.9               0.03


    As Adjusted                                                                                                                                               $421.4                             $319.1            $102.3           $61.7              $2.11
                                                                                                                                                              ======                             ======            ======           =====              =====



    (1) Impairment charges of $32.6 million on goodwill and $6.6 million on the customer relationships intangible asset of Nutri-Force.

    (2) In Fiscal 2016, charges primarily related to lease terminations and a $3.0 million tax benefit in the fiscal quarter ended December 2016
          resulting from the write-off of the Canada investment.  In Fiscal 2015, costs include inventory reserve charges, impairment charges to
          fixed assets and severance charges.

    (3) Management realignment charges primarily consist of severance, sign-on bonuses, recruiting and relocation costs.

    (4) The costs represent outside consultants fees in connection with the Company's "reinvention strategy".

    (5) Represents integration costs related to the acquisition of Nutri-Force, consisting primarily of professional fees.

    (6) In Fiscal 2016, costs primarily related to the closure of the Seattle distribution center.  In Fiscal 2015, conversion costs primarily
          include inventory reserve charges, product markdowns and accelerated depreciation.

    (7) Represents a charge to inventory reserves for the write-off of USPlabs(R)products which the Company ceased selling.

    (8) Outside consulting costs relating to a project to identify and implement cost reduction opportunities.

    (9) Represents a charge to increase the allowance for doubtful accounts for Nutri-Force, related to one wholesale customer that abruptly
         ceased operations.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vitamin-shoppe-inc-announces-fourth-quarter-2016-results-300415626.html

SOURCE Vitamin Shoppe, Inc.